Soleyman Bafadam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Soleyman Bafadam has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Amir Mohammad Aghaie
Faculty of Veterinary Medicine, Tabriz Medical Sciences Branch Islamic Azad University Tabriz Iran
1 shared publication- Behnaz Mokhtari
Alavi Aging Research Institute Tabriz University of Medical Sciences Tabriz Iran
1 shared publication - Fereydoun Rahmani
Department of Molecular Medicine, Faculty of Advanced Medical Science Tabriz University of Medical Sciences Tabriz Iran
1 shared publication Manoucheher Seyedi Vafaee
Psychiatry Research Unit Odense Denmark
1 shared publication- Maryam Mahmoudabady
Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication Mohammad Soukhtanloo
Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication
Latest Publications
- 5 February 2026
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 40 (2) , e70726
Exosome‐Derived Circular RNAs in Colorectal Cancer: Emerging Roles in Tumorigenesis, Diagnosis, and Therapy
Circular RNAs (circRNAs) are a class of non‐coding RNAs characterized by their covalently closed loop structures, which confer remarkable stability. Recent studies have highlighted the role of exosomal circRNAs, which are encapsulated within extracellular vesicles known as exosomes, in intercellular communication and tumor progression. In colorectal cancer (CRC), exosomal circRNAs have been implicated in various oncogenic processes, including cell proliferation, migration, invasion, epithelial‐mesenchymal transition (EMT), and drug resistance. These molecules exhibit dysregulated expression patterns in CRC tissues and bodily fluids, making them promising candidates for non‐invasive biomarkers. Moreover, their functional roles in modulating signaling pathways and the tumor microenvironment suggest their potential therapeutic applications. This review summarizes our current understanding of exosomal circRNA biology, highlights their roles in the CRC development and progression, and discusses their clinical significance as diagnostic, prognostic and therapeutic tools.
- 5 February 2026
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 40 (2) , e70726
Exosome‐Derived Circular RNAs in Colorectal Cancer: Emerging Roles in Tumorigenesis, Diagnosis, and Therapy
Circular RNAs (circRNAs) are a class of non‐coding RNAs characterized by their covalently closed loop structures, which confer remarkable stability. Recent studies have highlighted the role of exosomal circRNAs, which are encapsulated within extracellular vesicles known as exosomes, in intercellular communication and tumor progression. In colorectal cancer (CRC), exosomal circRNAs have been implicated in various oncogenic processes, including cell proliferation, migration, invasion, epithelial‐mesenchymal transition (EMT), and drug resistance. These molecules exhibit dysregulated expression patterns in CRC tissues and bodily fluids, making them promising candidates for non‐invasive biomarkers. Moreover, their functional roles in modulating signaling pathways and the tumor microenvironment suggest their potential therapeutic applications. This review summarizes our current understanding of exosomal circRNA biology, highlights their roles in the CRC development and progression, and discusses their clinical significance as diagnostic, prognostic and therapeutic tools.
- Open Access
- 13 March 2024
- Published by Wiley in Experimental Physiology
- Vol. 110 (5) , 744-754
Mitochondrial transplantation combined with coenzyme Q10 induces cardioprotection and mitochondrial improvement in aged male rats with reperfusion injury
Ischaemic heart diseases (IHD) are among the major causes of mortality in the elderly population. Although timely reperfusion is a common treatment for IHD, it causes additional damage to the ischaemic myocardium known as ischaemia–reperfusion (IR) injury. Considering the importance of preventing reperfusion injuries, we aimed to examine the combination effect of mitochondrial transplantation (MT) and coenzyme Q10 (CoQ10) in myocardial IR injury of aged male rats. Seventy‐two aged male Wistar rats were randomly divided into six groups: Sham, IR, CoQ10, MT, combination therapy (MT + CoQ10) and vehicle. Myocardial IR injury was established by occlusion of the left anterior descending coronary artery followed by reopening. Young male Wistar rats were used as mitochondria donors. Isolated mitochondria were injected intraventricularly (500 µL of a respiration buffer containing 6 × 106 ± 5 × 105 mitochondria/mL) in MT‐receiving groups at the onset of reperfusion. CoQ10 (10 mg/kg/day) was injected intraperitoneally for 2 weeks before IR induction. Twenty‐four hours after reperfusion, haemodynamic parameters, myocardial infarct size (IS), lactate dehydrogenase (LDH) release and cardiac mitochondrial function (mitochondrial reactive oxygen species (ROS) generation and membrane potential) were measured. The combination of MT and CoQ10 improved haemodynamic index changes and reduced IS and LDH release (P < 0.05). It also decreased mitochondrial ROS generation and increased membrane potential (P < 0.05). CoQ10 also showed a significant cardioprotective effect. Combination therapy displayed greater cardioprotective effects than single treatments. This study revealed that MT and CoQ10 combination treatment can be considered as a promising cardioprotective strategy to reduce myocardial IR injury in ageing, in part by restoring mitochondrial function.
- 13 March 2024
- Published by Wiley in Experimental Physiology
- Vol. 110 (5) , 744-754
Open AccessMitochondrial transplantation combined with coenzyme Q10 induces cardioprotection and mitochondrial improvement in aged male rats with reperfusion injury
Ischaemic heart diseases (IHD) are among the major causes of mortality in the elderly population. Although timely reperfusion is a common treatment for IHD, it causes additional damage to the ischaemic myocardium known as ischaemia–reperfusion (IR) injury. Considering the importance of preventing reperfusion injuries, we aimed to examine the combination effect of mitochondrial transplantation (MT) and coenzyme Q10 (CoQ10) in myocardial IR injury of aged male rats. Seventy‐two aged male Wistar rats were randomly divided into six groups: Sham, IR, CoQ10, MT, combination therapy (MT + CoQ10) and vehicle. Myocardial IR injury was established by occlusion of the left anterior descending coronary artery followed by reopening. Young male Wistar rats were used as mitochondria donors. Isolated mitochondria were injected intraventricularly (500 µL of a respiration buffer containing 6 × 106 ± 5 × 105 mitochondria/mL) in MT‐receiving groups at the onset of reperfusion. CoQ10 (10 mg/kg/day) was injected intraperitoneally for 2 weeks before IR induction. Twenty‐four hours after reperfusion, haemodynamic parameters, myocardial infarct size (IS), lactate dehydrogenase (LDH) release and cardiac mitochondrial function (mitochondrial reactive oxygen species (ROS) generation and membrane potential) were measured. The combination of MT and CoQ10 improved haemodynamic index changes and reduced IS and LDH release (P < 0.05). It also decreased mitochondrial ROS generation and increased membrane potential (P < 0.05). CoQ10 also showed a significant cardioprotective effect. Combination therapy displayed greater cardioprotective effects than single treatments. This study revealed that MT and CoQ10 combination treatment can be considered as a promising cardioprotective strategy to reduce myocardial IR injury in ageing, in part by restoring mitochondrial function.
- Open Access
- 13 January 2021
- Published by Maad Rayan Publishing Company in Journal of Cardiovascular and Thoracic Research
- Vol. 13 (1) , 28-36
Cardioprotective effects of Fenugreek (Trigonella foenum-graceum) seed extract in streptozotocin induced diabetic rats
Introduction: Inadequate control of diabetes mellitus (DM) leads to considerable cardiovascular implications like diabetic cardiomyopathy (DCM). Cardiomyocyte apoptosis is one of the main mechanisms of DCM pathogenesis associated with hyperglycemia, oxidative stress, inflammation, hyperlipidemia and several other factors. Trigonella foenum-graecum (Fenugreek) has been long used as a traditional medicine and has many therapeutic effects, including anti-diabetic, anti-hyperlipidemia, anti-inflammatory and anti-oxidant properties. The current study aimed to investigate cardioprotective effects of fenugreek seed on diabetic rats. Methods: Diabetes was induced in forty-two male rats by injection of streptozotocin (STZ) (60 mg/ kg). Diabetic animals were treated with three different doses of fenugreek seed extract (50, 100 and 200 mg/kg) or metformin (300 mg/kg) for six weeks by gavage. Nondiabetic rats served as controls. Glucose, cholesterol, and triglycerides levels were measured in the blood samples, and oxidative stress markers as well as gene expression of ICAM1, Bax and Bcl2 were assessed in the cardiac tissues of the experimental groups. Results: Diabetic rats exhibited increased serum glucose, cholesterol and triglycerides levels, elevated markers of oxidative stress thiobarbituric acid–reacting substances (TBARS) levels , total thiol groups (SH), catalase (CAT) and superoxide dismutase (SOD) activity, and enhanced apoptosis cell death (ratio of Bax/Bcl2). Fenugreek seed extract considerably improved metabolism abnormalities, attenuated oxidative stress and diminished apoptosis index. Conclusion: Our study suggests that fenugreek seed may protect the cardiac structure in STZ-induced diabetic rats by attenuating oxidative stress and apoptosis.
- 13 January 2021
- Published by Maad Rayan Publishing Company in Journal of Cardiovascular and Thoracic Research
- Vol. 13 (1) , 28-36
Open AccessCardioprotective effects of Fenugreek (Trigonella foenum-graceum) seed extract in streptozotocin induced diabetic rats
Introduction: Inadequate control of diabetes mellitus (DM) leads to considerable cardiovascular implications like diabetic cardiomyopathy (DCM). Cardiomyocyte apoptosis is one of the main mechanisms of DCM pathogenesis associated with hyperglycemia, oxidative stress, inflammation, hyperlipidemia and several other factors. Trigonella foenum-graecum (Fenugreek) has been long used as a traditional medicine and has many therapeutic effects, including anti-diabetic, anti-hyperlipidemia, anti-inflammatory and anti-oxidant properties. The current study aimed to investigate cardioprotective effects of fenugreek seed on diabetic rats. Methods: Diabetes was induced in forty-two male rats by injection of streptozotocin (STZ) (60 mg/ kg). Diabetic animals were treated with three different doses of fenugreek seed extract (50, 100 and 200 mg/kg) or metformin (300 mg/kg) for six weeks by gavage. Nondiabetic rats served as controls. Glucose, cholesterol, and triglycerides levels were measured in the blood samples, and oxidative stress markers as well as gene expression of ICAM1, Bax and Bcl2 were assessed in the cardiac tissues of the experimental groups. Results: Diabetic rats exhibited increased serum glucose, cholesterol and triglycerides levels, elevated markers of oxidative stress thiobarbituric acid–reacting substances (TBARS) levels , total thiol groups (SH), catalase (CAT) and superoxide dismutase (SOD) activity, and enhanced apoptosis cell death (ratio of Bax/Bcl2). Fenugreek seed extract considerably improved metabolism abnormalities, attenuated oxidative stress and diminished apoptosis index. Conclusion: Our study suggests that fenugreek seed may protect the cardiac structure in STZ-induced diabetic rats by attenuating oxidative stress and apoptosis.